Oncology Test
Hereditary Cancer Risk Assessment
CommercialActive
Key Facts
About Genematrix
Genematrix is a private, commercial-stage diagnostics company leveraging artificial intelligence and genetic sequencing to deliver rapid, actionable health insights. Its core offering is a comprehensive hereditary cancer risk panel, but it has expanded into a broad portfolio including pharmacogenomics, wellness, nutrition, and family planning tests, all marketed through a direct-to-consumer subscription model. Positioned at the intersection of AI, genomics, and digital health, the company aims to enable early disease detection and personalized treatment plans to transform preventive healthcare.
View full company profileTherapeutic Areas
Other Hereditary Cancer Risk Assessment Drugs
| Drug | Company | Phase |
|---|---|---|
| Hereditary Tumor Gene Panel | DeltaGene | Commercial |
| +RNAinsight® for Hereditary Cancer | Ambry Genetics | Commercial |